Prediction and characterization of helper T-cell epitopes from pneumococcal surface adhesin A

Immunology

Volumn 141, Issue 4, 2014, Pages 514-530

  Singh, Rajesh ^a   Gupta, Pranav ^a   Sharma, Praveen K ^b   Ades, Edwin W ^c   Hollingshead, Susan K ^d   Singh, Shailesh ^a   Lillard, James W ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b CENTRAL UNIVERSITY OF JHARKHAND   (India)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

MHC; Peptide vaccine; Streptococcus pneumoniae; T helper type 1 2 cytokine

Indexed keywords

ADHESIN; ASPARAGINE; CD4 ANTIGEN; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; PNEUMOCOCCAL SURFACE ADHESIN A; PROTEINASE; UNCLASSIFIED DRUG;

ALLELE; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM ISOLATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CERVICAL LYMPH NODE; COMPUTER MODEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; EX VIVO STUDY; FEMALE; HELPER CELL; HLA SYSTEM; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; SPLEEN; STREPTOCOCCUS PNEUMONIAE;

MHC; PEPTIDE VACCINE; STREPTOCOCCUS PNEUMONIAE; T HELPER TYPE 1/2 CYTOKINE;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL PROTEINS; CELL PROLIFERATION; COCULTURE TECHNIQUES; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; FEEDER CELLS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; INTERFERON-GAMMA; INTERLEUKINS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PNEUMOCOCCAL INFECTIONS; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; SPLEEN; STREPTOCOCCUS PNEUMONIAE; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84895789937     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12194     Document Type: Article

References (51)

1. Hausdorff WP, Bryant J, Paradiso PR, Siber GR. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 2000; 30:100-21.
2. Berkley JA, Lowe BS, Mwangi I et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 2005; 352:39-47.
3. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3:171-96.
4. Rajam G, Anderton JM, Carlone GM, Sampson JS, Ades EW. Pneumococcal surface adhesin A (PsaA): a review. Crit Rev Microbiol 2008; 34:131-42.
5. Sampson JS, Furlow Z, Whitney AM, Williams D, Facklam R, Carlone GM. Limited diversity of Streptococcus pneumoniae psaA among pneumococcal vaccine serotypes. Infect Immun 1997; 65:1967-71.
6. Morrison KE, Lake D, Crook J, Carlone GM, Ades E, Facklam R, Sampson JS. Confirmation of psaA in all 90 serotypes of Streptococcus pneumoniae by PCR and potential of this assay for identification and diagnosis. J Clin Microbiol 2000; 38:434-7.
7. Dintilhac A, Alloing G, Granadel C, Claverys JP. Competence and virulence of Streptococcus pneumoniae: Adc and PsaA mutants exhibit a requirement for Zn and Mn resulting from inactivation of putative ABC metal permeases. Mol Microbiol 1997; 25:727-39.
8. McAllister LJ, Tseng H-J, Ogunniyi AD, Jennings MP, McEwan AG, Paton JC. Molecular analysis of the psa permease complex of Streptococcus pneumoniae. Mol Microbiol 2004; 53:889-901.
9. Briles DE, Ades E, Paton JC et al. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect Immun 2000; 68:796-800.
10. Palaniappan R, Singh S, Singh UP et al. Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage. Infect Immun 2005; 73:1006-13.
11. Hammer J, Sturniolo T, Sinigaglia F. HLA class II peptide binding specificity and autoimmunity. Adv Immunol 1997; 66:67-100.
12. Sturniolo T, Bono E, Ding J et al. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol 1999; 17:555-61.
13. Sette A, Fleri W, Peters B, Sathiamurthy M, Bui H-H, Wilson S. A roadmap for the immunomics of category A-C pathogens. Immunity 2005; 22:155-61.
14. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanović S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999; 50:213-9.
15. Reche PA, Glutting J-P, Zhang H, Reinherz EL. Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles. Immunogenetics 2004; 56:405-19.
16. Dönnes P, Kohlbacher O. SVMHC: a server for prediction of MHC-binding peptides. Nucleic Acids Res 2006; 34:W194-7.
17. Parry CS. Flanking p10 contribution and sequence bias in matrix based epitope prediction: revisiting the assumption of independent binding pockets. BMC Struct Biol 2008; 8:44.
18. Ridgway WM, Fathman CG. MHC structure and autoimmune T cell repertoire development. Curr Opin Immunol 1999; 11:638-42.
19. Gregersen PK. HLA class II polymorphism: implications for genetic susceptibility to autoimmune disease. Lab Invest 1989; 61:5-19.
20. Briles DE, Crain MJ, Gray BM, Forman C, Yother J. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect Immun 1992; 60:111-6.
21. Aaberge IS, Eng J, Lermark G, Løvik M. Virulence of Streptococcus pneumoniae in mice: a standardized method for preparation and frozen storage of the experimental bacterial inoculum. Microb Pathog 1995; 18:141-52.
22. McGuffin LJ, Bryson K, Jones DT. The PSIPRED protein structure prediction server. Bioinformatics (Oxford, England) 2000; 16:404-5.
23. Fuchs PFJ, Alix AJP. High accuracy prediction of β-turns and their types using propensities and multiple alignments. Proteins 2005; 59:828-39.
24. Manoury B, Hewitt EW, Morrice N, Dando PM, Barrett AJ, Watts C. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature 1998; 396:695-9.
25. Reche PA, Reinherz EL. Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms. J Mol Biol 2003; 331:623-41.
26. Yu J-J, Goluguri T, Guentzel MN, Chambers JP, Murthy AK, Klose KE, Forsthuber TG, Arulanandam BP. Francisella tularensis T-cell antigen identification using humanized HLA-DR4 transgenic mice. Clin Vaccine Immunol 2010; 17:215-22.
27. Ottenhoff TH, Walford C, Nishimura Y, Reddy NB, Sasazuki T. HLA-DQ molecules and the control of Mycobacterium leprae-specific T cell nonresponsiveness in lepromatous leprosy patients. Eur J Immunol 1990; 20:2347-50.
28. Bono MR, Strominger JL. Direct evidence of homology between human DC-1 antigen and murine I-A molecules. Nature 1982; 299:836-40.
29. Hurley CK, Nunez G, Winchester R, Finn OJ, Levy R, Capra JD. The human HLA-DR antigens are encoded by multiple β-chain loci. J Immunol (Baltimore, Md: 1950) 1982; 129:2103-8.
30. Singh R, Singh S, Sharma PK, Singh UP, Briles DE, Hollingshead SK, Lillard JW. Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A. PLoS ONE 2010; 5:e9432.
31. Marqués JM, Rial A, Muñoz N et al. Protection against Streptococcus pneumoniae serotype 1 acute infection shows a signature of Th17- and IFN-γ-mediated immunity. Immunobiology 2012; 217:420-9.
32. Rubins JB, Pomeroy C. Role of γ interferon in the pathogenesis of bacteremic pneumococcal pneumonia. Infect Immun 1997; 65:2975-7.
33. Weigent DA, Huff TL, Peterson JW, Stanton GJ, Baron S. Role of interferon in streptococcal infection in the mouse. Microb Pathog 1986; 1:399-407.
34. Sun K, Metzger DW. Inhibition of pulmonary antibacterial defense by interferon-γ during recovery from influenza infection. Nat Med 2008; 14:558-64.
35. Khan AQ, Shen Y, Wu Z-Q, Wynn TA, Snapper CM. Endogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae. Infect Immun 2002; 70:749-61.
36. Tsuchiya K, Komori M, Zheng QY, Ferrieri P, Lin J. Interleukin-10 is an essential modulator of mucoid metaplasia in a mouse otitis media model. Ann Otol Rhinol Laryngol 2008; 117:630-6.
37. van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 1996; 174:994-1000.
38. Palaniappan R, Singh S, Singh UP et al. CCL5 modulates pneumococcal immunity and carriage. J Immunol (Baltimore, Md: 1950) 2006; 176:2346-56.
39. Yu X, Sperling A, Blair C, Thompson K, Naclerio R. Antigen stimulation of TH2 cells augments acute bacterial sinusitis in mice. J Allergy Clin Immunol 2004; 114:328-34.
40. Kang CI, Rouse MS, Patel R, Kita H, Juhn YJ. Allergic airway inflammation and susceptibility to pneumococcal pneumonia in a murine model with real-time in vivo evaluation. Clin Exp Immunol 2009; 156:552-61.
41. Curtis MM, Way SS. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 2009; 126:177-85.
42. Malley R, Srivastava A, Lipsitch M, Thompson CM, Watkins C, Tzianabos A, Anderson PW. Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect Immun 2006; 74:2187-95.
43. Lu Y-J, Gross J, Bogaert D et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 2008; 4:e1000159.
44. Lu Y-J, Forte S, Thompson CM, Anderson PW, Malley R. Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide. Infect Immun 2009; 77:2076-83.
45. H17-based vaccine design for prevention of Streptococcus pneumoniae colonization. Cell Host Microbe 2011; 9:158-65.
46. Li Y, Gierahn T, Thompson MC et al. Distinct effects on diversifying selection by two mechanisms of immunity against Streptococcus pneumoniae. PLoS Pathog 2012; 8:e1002989.
47. Villadangos JA, Riese RJ, Peters C, Chapman HA, Ploegh HL. Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism. J Exp Med 1997; 186:549-60.
48. Manoury B, Mazzeo D, Fugger L et al. Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP. Nat Immunol 2002; 3:169-74.
49. Amigorena S, Webster P, Drake J, Newcomb J, Cresswell P, Mellman I. Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles. J Exp Med 1995; 181:1729-41.
50. Antoniou AN, Blackwood SL, Mazzeo D, Watts C. Control of antigen presentation by a single protease cleavage site. Immunity 2000; 12:391-8.
51. Castellino F, Zappacosta F, Coligan JE, Germain RN. Large protein fragments as substrates for endocytic antigen capture by MHC class II molecules. J Immunol (Baltimore, Md: 1950) 1998; 161:4048-57.